Effect of regular physical activity on non-lipid (novel) cardiovascular risk factors

International Journal of Occupational Medicine and Environmental Health

Volumn 24, Issue 4, 2011, Pages 380-390

  Naghii, Mohammad Reza ^a   Aref, Mraryam Alem ^a   Almadadi, Mehdi ^a   Hedayati, Mehdi ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokines; Military personnel; Non lipid cardiovascular risk factors; Physical activity

Indexed keywords

CYTOKINE; FOLIC ACID; HOMOCYSTEINE; TESTOSTERONE; VITAMIN D;

ADULT; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; EXERCISE; HUMAN; IRAN; PHYSIOLOGY; RISK FACTOR; SEDENTARY LIFESTYLE; SOLDIER;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CYTOKINES; EXERCISE; FOLIC ACID; HOMOCYSTEINE; HUMANS; IRAN; MILITARY PERSONNEL; RISK FACTORS; SEDENTARY LIFESTYLE; TESTOSTERONE; VITAMIN D; YOUNG ADULT;

EID: 84858762135     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: 10.2478/s13382-011-0044-9     Document Type: Article

References (46)

1. Thelle DS. The causal role of blood lipids in the aetiology of coronary heart disease-an epidemiologist's perspective. Scand Cardiovasc J 2008;42:274-8.
2. Greenfeder S. Emerging strategies and agents to lower cardio-vascular risk by increasing high density lipoprotein cholesterol levels. Curr Med Chem 2009;16:144-56.
3. Norata GD, Catapano AL. Molecular mechanisms responsi-ble for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag 2005;1:119-29.
4. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treat-ment Panel III guidelines. Circulation 2004;110:227-39. (Pubitemid 38924592)
5. Singh IM, Shishehbor MH, Ansell BJ. High-density lipoprotein as a therapeutic target: a systematic review. JAMA 2007;298: 786-98. (Pubitemid 47263161)
6. Powers E, Saultz J, Hamilton A, Lo V. Clinical inquiries. Which lifestyle interventions effectively lower LDL cholesterol? J Fam Pract 2007;56:483-5. (Pubitemid 47015397)
7. Volaklis KA, Spassis AT, Tokmakidis SP. Land versus wa-ter exercise in patients with coronary artery disease: effects on body composition, blood lipids, and physical fitness. Am Heart J 2007;154:560.e1-6.
8. National Institute of Diabetes and Digestive and Kidney Disease. Understanding Adult Obesity. National Institutes of Health (NIH) Publication No. 06-3680. November 2008. Bethesda, MD.: U.S. Department of Health and Hu-man Services; 2008. [2011 June 13]. Available from URL: http://win.niddk.nih.gov/ publications/understanding.htm.
9. Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stew-art KJ, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scien tific statement from the Council on Clinical Cardiology. Circulation 2005;111:369-76.
10. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fon-arow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72. (Pubitemid 43947981)
11. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Mur-ray CJ. Global and regional burden of disease and risk fac-tors, 2001: systematic analysis of population health data. Lan-cet 2006;367:1747-57. (Pubitemid 43767064)
12. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomiji-ma N, Rodgers A, et al. Effectiveness and costs of interven-tions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003;361:717-25. (Pubitemid 36293625)
13. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization; 2004 [2011 June 13]. Available from URL: http://www.who.int/cardiovascular-diseases/resources/atlas/en/index.html
14. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Bre-ner SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898-904. (Pubitemid 37430461)
15. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Wil-liams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005;293:1868-74. (Pubitemid 40548183)
16. Libby P. The forgotten majority: unfinished business in cardio-vascular risk reduction. J Am Coll Cardiol 2005;46:1225-8. (Pubitemid 41615541)
17. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interven-tions to prevent or delay type 2 diabetes in people with im-paired glucose tolerance: systematic review and meta-analysis. BMJ 2007;334:299.
18. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circula-tion 2006;114:2850-70. (Pubitemid 46018288)
19. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Frank-lin BA, et al. Physical activity and public health: updated re-commendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007;39:1423-34. (Pubitemid 47344026)
20. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential me-diating mechanisms. Circulation 2007;116:2110-8. (Pubitemid 350060348)
21. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002;105:2696-8. (Pubitemid 34615135)
22. Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004;109:1112-7.
23. Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with poly-cystic ovary syndrome. Gynecol Endocrinol 2007;23:505-10. (Pubitemid 47628538)
24. Karatela RA, Sainani GS. Plasma homocysteine in obese, overweight and normal weight hypertensives and normoten-sives. Indian Heart J 2009;61:156-9.
25. Alipour M, Sohrabi D, Falah R, Heydarpour F, Mo-hammadi M. Effect of aerobic moderate exercise intensity and 15-F21-isoprostane concentrations in high cholesterol diet-induced atherosclerosis. Physiol Pharmacol 2007;11:199-207.
26. Soysal D, Sava? S, Susam I, Cevik C, Göldeli E, Sözmen E, et al. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery dis-ease, vascular syndrome x and healthy subjects. Anadolu Kardiyol Derg 2003;3:26-34. (Pubitemid 36355815)
27. Liao D, Yang X, Wang H. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease. Clin Chem Lab Med 2007;45:1652-9. (Pubitemid 350232983)
28. Yun J, Kim JY, Kim OY, et al. Associations of plasma ho-mocysteine level with brachial-ankle pulse wave velocity and inflammation profile in healthy men. Nutr Metab Cardiovasc Dis 2011;21(2):136-43.
29. Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, et al. Hyper-homocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhanc-ing HDL cholesterol clearance. Circ Res 2006;99:598-606. (Pubitemid 44401451)
30. Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bul-bulia R, Rahimi K, et al. Effect of homocysteine-lowering with folic acid plus vitamin B12 vs. placebo on mortality and major morbidity in myocardial infarction survivors. JAMA 2010;303:2486-94.
31. Su SC, Pei D, Hsieh CH, Hsiao FC, Wu CZ, Hung YJ. Cir-culating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes. Acta Diabetol 2011;48(2):113-9.
32. Moreno SA, Shyam A, Morgentaler A. Comparison of free testosterone results by analog radioimmunoassay and calculat-ed free testosterone in an ambulatory clinical population. J Sex Med 2010;7:1948-53.
33. Al-Qahtani DA, Imtiaz ML, Shareef MM. Obesity and car-diovascular risk factors in Saudi adult soldiers. Saudi Med J 2005;26:1260-8. (Pubitemid 41288641)
34. Al-Qahtani DA, Imtiaz ML. Prevalence of metabolic syn-drome in Saudi adult soldiers. Saudi Med J 2005;26:1360-6. (Pubitemid 41479320)
35. Khazale NS, Haddad F. Prevalence and characteristics of meta bolic syndrome in 111 Royal Jordanian Air Force pilots. Aviat Space Environ Med 2007;78:968-72. (Pubitemid 47511956)
36. Mikkola I, Keinänen-Kiukaanniemi S, Laakso M, Jokelain-en J, Härkönen P, Meyer-Rochow VB, et al. Metabolic syn-drome in connection with BMI in young Finnish male adults. Diabetes Res Clin Pract 2007;76:404-9. (Pubitemid 46505038)
37. Laclaustra-Gimeno M, González-García MP, Casasnovas-Lenguas JA, Luengo-Fernández E, León-Latre M, Portero-Pérez P, et al. Cardiovascular risk factor progression in young males at 15-year follow-up in the General Military Academy of Zaragoza (AGEMZA) Study. Rev Esp Cardiol 2006;59: 671-8. (Pubitemid 44349816)
38. Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001;33(6 Suppl):S502-15. (Pubitemid 32524744)
39. Jakicic JM, Marcus BH, Gallagher KI, Napolitano M, Lang W. Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial. JAMA 2003;290:1323-30. (Pubitemid 37442628)
40. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, et al. Exercise and physical activity in the preven-tion and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcom-mittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Sub-committee on Physical Activity). Circulation 2003;107:3109-16. (Pubitemid 36758987)
41. Norton L. Vigorous physical activity for 40 days may reduce cardiovascular risk factors. Abstract 747. American College of Sports Medicine (ACSM) 55th Annual Meeting; 2008 May 28-31, Indianapolis, USA. Medscape Medical News, 2008 [2011 June 13]. Available from: http://www.medscape. com/viewarticle/575585.
42. Centers for Disease Control and Prevention (CDC). Prevalence of regular physical activity among adults-United States, 2001 and 2005. MMWR Morb Mortal Wkly Rep 2007;56:1209-12.
43. Pepys MB, Hirschfield GM. C-reactive protein: a critical up-date. J Clin Invest 2003;111:1805-12.
44. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adi-pokines: molecular links between obesity and atheroslcero-sis. Am J Physiol Heart Circ Physiol 2005;288:H2031-41. (Pubitemid 40604084)
45. Lee JH, Gadi R, Spertus JA, Tang F, O'Keefe JH. Prevalence of vitamin D deficiency in patients with acute myocardial in-farction. Am J Cardiol 2011;107:1636-8.
46. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011;86:50-60.